Fifth Third Bancorp
TVTX icon

Fifth Third Bancorp’s Travere Therapeutics TVTX Stock Holding History

Fifth Third Bancorp’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.4K Buy
+1,191
New +$35.6K ﹤0.01% 3322
2025
Q4 		– Sell
-63
Closed -$1.51K – 2744
2025
Q3 		$1.51K Buy
+63
New +$1.18K ﹤0.01% 2486
2019
Q1 		– Sell
-195
Closed -$4K – 2307
2018
Q4 		$4K Buy
+195
New +$4.85K ﹤0.01% 2022
2016
Q4 		– Sell
-450
Closed -$10K – 2288
2016
Q3 		$10K Buy
+450
New +$8.57K ﹤0.01% 1835

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fifth Third Bancorp's TVTX Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Travere Therapeutics (TVTX) in Q1 2026: 1,191 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #3322 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in TVTX as recently as Q3 2025.

Fifth Third Bancorp first reported a position in TVTX in Q3 2016 and has held it in 4 quarters since. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Fifth Third Bancorp held 1,191 shares of Travere Therapeutics worth $35.4K as of Q1 2026.
  • Travere Therapeutics was a new Fifth Third Bancorp position in Q1 2026.
  • Travere Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3322 holding.
  • Fifth Third Bancorp first reported a position in Travere Therapeutics in Q3 2016 and has held it in 4 quarters since.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.